Breakthrough in Early Disease Diagnosis: Shandong University Study Reveals Promising Tool for ESOC Diagnosis

Shandong University researchers have made a significant breakthrough in developing a platform for detecting a panel of proteomic biomarkers for accurate early diagnosis of esophageal squamous cell carcinoma (ESCC). The innovative method combines a barcode immunoassay biochip with machine learning, achieving an accuracy of 91.0% in external validation and 90.8% in detecting early-stage ESCC. This represents a substantial improvement over the current biomarker, which has an accuracy of only 14.4% for squamous cell carcinoma.

Key Takeaways:

The study utilized a barcode immunoassay biochip to capture small extracellular vesicles (EVs) from serum and quantify multiple proteins, including membrane and internal proteins of EVs.
The biochip was used to test 273 clinical samples across multiple centers, and the validation sets were analyzed using machine learning to develop a precise diagnostic model for ESCC.
The developed extracellular vesicles analysis platform offers a promising tool for the clinical application of multi-biomarker detection methods, advancing the early diagnosis of ESCC.
The method identified nine diagnostic protein biomarkers through mass spectrometry analysis of differentially expressed proteins.
The research was supported by the Major Scientific and Technological Innovation Project of Shandong Province and the National Science Foundation.
The study's lead author, Lin Han, of Shandong University, emphasized the significance of the research, stating that the developed platform presents a promising tool for the clinical application of multi-biomarker detection methods.

Statistics:

The developed platform achieved an accuracy of 91.0% in external validation.
The accuracy of detecting early-stage ESCC was 90.8%.
The currently used biomarker for squamous cell carcinoma has an accuracy of only 14.4% for ESCC.
The research utilized 273 clinical samples across multiple centers.
The biochip captured small extracellular vesicles (EVs) from serum and quantified multiple proteins, including membrane and internal proteins of EVs.

Sources:

"Microfluidic Biochip-based Multiplexed Profiling of Small Extracellular Vesicles Proteins Integrated With Machine Learning for Early Disease Diagnosis." Advanced Science, 2025.
"Findings on Biomarkers Detailed by Investigators at Shandong University." Health & Medicine Week, August 1, 2025; p 145.
American Scientific Publishers. "Advanced Science." (www.aspbs.com)